Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki

Detalhes bibliográficos
Autor(a) principal: Sousa, Maria de Jesus Rios
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/33456
Resumo: Aquatic ecosystems are threatened by factors related to climate change, leading to changes in the physical and chemical water properties. Between these changes, and as a consequence of global warming and extreme weather events, coastal systems are facing sudden fluctuations in salinity. Aquatic ecosystems are also threatened by organic and inorganic compounds that increase water pollution. Metformin is an antidiabetic drug commonly used by patients of diabetes type 2. It is also used as a treatment for polycystic ovary syndrome and as an anti-cancer drug. Metformin is not metabolized by the human body and has high watery mobility. Because wastewater treatment plants have low efficacy in removing these compounds, they may reach in the aquatic environment. The aim of this study was to evaluate the influence of different salinity levels (17, 24 means control, 31) on the effects of metformin (0-Control, 1.5, 15, 150 μ/L) in Gambusia holbrooki after acute exposure (96h). A chronic exposure was also performed to assess the effects of metformin (0-Control, 0.5, 1, 5, 10 μ/L) in G. holbrooki at salinity 17 for 28 days. For both assays, several biomarkers were quantified in the exposure organisms to assess: antioxidant capacity (superoxide dismutase-SOD, catalase-CAT, glutathione peroxidase-GPx, glutathione reductase-GRed) and biotransformation capacity (glutathione S-transferases-GSTs), cellular damage (levels of lipid peroxidation-TBARS), content of energy reserves (head and body protein levels- PROT, glycogen content- GLY) and neurotoxic effects (acetylcholinesterase-AChE). The results obtain from acute exposure showed interactions between salinity and metformin in SOD activity, body PROT levels and GLY content in G. holbrooki. The data obtain showed that an increase in salinity can modulate the response of the G. holbrooki to metformin. The results obtain from the chronic assay, showed that exposure of G. holbrooki to metformin led to a significant decrease in SOD activity at almost all concentrations tested. In addition, GPx and GSTs activity increased significantly at the concentration of metformin 10 and 5 μ/L, respectively. Therefore, metformin can lead to oxidative stress in G. holbrooki. Overall, the GLY content in G. holbrooki increased after exposure to metformin concentrations. No significant effects were observed in the remaining biomarkers measured. Although this work does not show a full oxidative stress scenario in G. holbrooki after exposure to metformin under different salinities, other studies have already shown that metformin alone can lead to oxidative damage in aquatic species. Therefore, additional ecotoxicological studies should be performed to find out if different metformin concentrations combined with salinity increase might impact non-target species.
id RCAP_5d610590235287314a8d35f9e4c05d5c
oai_identifier_str oai:ria.ua.pt:10773/33456
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrookiClimate changeSalinityMetforminGambusia holbrookiOxidative stressEnergy reservesNeurotoxicityAquatic ecosystems are threatened by factors related to climate change, leading to changes in the physical and chemical water properties. Between these changes, and as a consequence of global warming and extreme weather events, coastal systems are facing sudden fluctuations in salinity. Aquatic ecosystems are also threatened by organic and inorganic compounds that increase water pollution. Metformin is an antidiabetic drug commonly used by patients of diabetes type 2. It is also used as a treatment for polycystic ovary syndrome and as an anti-cancer drug. Metformin is not metabolized by the human body and has high watery mobility. Because wastewater treatment plants have low efficacy in removing these compounds, they may reach in the aquatic environment. The aim of this study was to evaluate the influence of different salinity levels (17, 24 means control, 31) on the effects of metformin (0-Control, 1.5, 15, 150 μ/L) in Gambusia holbrooki after acute exposure (96h). A chronic exposure was also performed to assess the effects of metformin (0-Control, 0.5, 1, 5, 10 μ/L) in G. holbrooki at salinity 17 for 28 days. For both assays, several biomarkers were quantified in the exposure organisms to assess: antioxidant capacity (superoxide dismutase-SOD, catalase-CAT, glutathione peroxidase-GPx, glutathione reductase-GRed) and biotransformation capacity (glutathione S-transferases-GSTs), cellular damage (levels of lipid peroxidation-TBARS), content of energy reserves (head and body protein levels- PROT, glycogen content- GLY) and neurotoxic effects (acetylcholinesterase-AChE). The results obtain from acute exposure showed interactions between salinity and metformin in SOD activity, body PROT levels and GLY content in G. holbrooki. The data obtain showed that an increase in salinity can modulate the response of the G. holbrooki to metformin. The results obtain from the chronic assay, showed that exposure of G. holbrooki to metformin led to a significant decrease in SOD activity at almost all concentrations tested. In addition, GPx and GSTs activity increased significantly at the concentration of metformin 10 and 5 μ/L, respectively. Therefore, metformin can lead to oxidative stress in G. holbrooki. Overall, the GLY content in G. holbrooki increased after exposure to metformin concentrations. No significant effects were observed in the remaining biomarkers measured. Although this work does not show a full oxidative stress scenario in G. holbrooki after exposure to metformin under different salinities, other studies have already shown that metformin alone can lead to oxidative damage in aquatic species. Therefore, additional ecotoxicological studies should be performed to find out if different metformin concentrations combined with salinity increase might impact non-target species.Os ecossistemas aquáticos são ameaçados por vários fatores relacionados com as alterações climáticas, levando a modificações nas propriedades físicas e químicas da água. Entre essas alterações, e como consequência do aquecimento global e de eventos climáticos extemos, os ecossistemas costeiros estão a enfrentar flutuações repentinas na salinidade. Os ecossistemas aquáticos são também ameaçados por compostos orgânicos e inorgânicos que aumentam a poluição da água. A metformina é um medicamento antidiabético usualmente utilizado por pacientes com diabetes tipo 2. É também utilizada no tratamento da síndrome do ovário poliquístico e como um medicamento anticancerígeno. A metformina não é metabolizada pelo corpo humano e tem uma alta mobilidade aquosa. Devido à baixa eficiência na remoção destes compostos pelas estações de tratamentos de águas residuais, a metformina pode chegar aos ambientes aquáticos. O objetivo deste estudo é avaliar a influência dos diferentes níveis de salinidade (17, 24- controlo, 31) nos efeitos da metformina (0- Controlo, 1.5, 15, 150 μ/L) em Gambusia holbrooki após uma exposição aguda (96h). Uma exposição crónica também foi realizada para aferir os efeitos da metformina (0- Controlo, 0.5, 1, 5, 10 μ/L) em G. holbrooki na salinidade 17 durante 28 dias. Para ambos os ensaios, vários biomarcadores foram quantificados nos organismos expostos para aferir: a capacidade antioxidante (superóxido dismutase- SOD, catalase- CAT, glutationa peroxidase- GPx, glutationa redutase- GRed) e capacidade de biotransformação (glutationa S-transferases- GSTs), dano celular (níveis de peroxidação lipídica- TBARs), conteúdo de reservas energéticas (níveis de proteína do corpo e da cabeça- PROT; conteúdo de glicogénio- GLY) e efeitos neurotóxicos (acetilcolinesterase- AChE). Os resultados obtidos da exposição aguda mostram interações entre a salinidade e a metformina na atividade da SOD, níveis de PROT do corpo e conteúdo de GLY em G.holbrooki. Os dados extraídos mostram que um aumento da salinidade pode alterar a resposta de G.holbrooki à metformina. Os resultados obtidos da exposição crónica, mostraram que a exposição de G.holbrooki à metformina levou a uma diminuição significativa da atividade da SOD em quase todas as concentrações testadas. Além disso, a atividade da GPX e das GSTs aumentou, significativamente, nas concentrações de metformina de 10 e de 5 μ/L, respetivamente. Assim sendo, a metformina pode levar ao stress oxidativo em G.holbrooki. No geral, o conteúdo de GLY em G.holbrooki aumentou após a exposição ás concentrações de metformina. Não foram observados efeitos significativos nos restantes biomarcadores medidos. Apesar deste trabalho não mostrar um cenário completo de stress oxidativo em G.holbrooki, após a exposição à metformina em diferentes salinidades, outros estudos já revelaram que a metformina pode levar a danos oxidativos em espécies aquáticas. Assim, estudos ecotoxicológicos adicionais devem ser realizados para descobrir se diferentes concentrações de metformina combinadas com um aumento da salinidade podem ter impactos em espécies não alvo.2022-03-11T12:02:01Z2021-12-10T00:00:00Z2021-12-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/33456engSousa, Maria de Jesus Riosinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T12:04:21Zoai:ria.ua.pt:10773/33456Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:04:52.914129Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
title Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
spellingShingle Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
Sousa, Maria de Jesus Rios
Climate change
Salinity
Metformin
Gambusia holbrooki
Oxidative stress
Energy reserves
Neurotoxicity
title_short Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
title_full Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
title_fullStr Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
title_full_unstemmed Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
title_sort Evaluation of the ecotoxicological effects of salinity and metformin in Gambusia holbrooki
author Sousa, Maria de Jesus Rios
author_facet Sousa, Maria de Jesus Rios
author_role author
dc.contributor.author.fl_str_mv Sousa, Maria de Jesus Rios
dc.subject.por.fl_str_mv Climate change
Salinity
Metformin
Gambusia holbrooki
Oxidative stress
Energy reserves
Neurotoxicity
topic Climate change
Salinity
Metformin
Gambusia holbrooki
Oxidative stress
Energy reserves
Neurotoxicity
description Aquatic ecosystems are threatened by factors related to climate change, leading to changes in the physical and chemical water properties. Between these changes, and as a consequence of global warming and extreme weather events, coastal systems are facing sudden fluctuations in salinity. Aquatic ecosystems are also threatened by organic and inorganic compounds that increase water pollution. Metformin is an antidiabetic drug commonly used by patients of diabetes type 2. It is also used as a treatment for polycystic ovary syndrome and as an anti-cancer drug. Metformin is not metabolized by the human body and has high watery mobility. Because wastewater treatment plants have low efficacy in removing these compounds, they may reach in the aquatic environment. The aim of this study was to evaluate the influence of different salinity levels (17, 24 means control, 31) on the effects of metformin (0-Control, 1.5, 15, 150 μ/L) in Gambusia holbrooki after acute exposure (96h). A chronic exposure was also performed to assess the effects of metformin (0-Control, 0.5, 1, 5, 10 μ/L) in G. holbrooki at salinity 17 for 28 days. For both assays, several biomarkers were quantified in the exposure organisms to assess: antioxidant capacity (superoxide dismutase-SOD, catalase-CAT, glutathione peroxidase-GPx, glutathione reductase-GRed) and biotransformation capacity (glutathione S-transferases-GSTs), cellular damage (levels of lipid peroxidation-TBARS), content of energy reserves (head and body protein levels- PROT, glycogen content- GLY) and neurotoxic effects (acetylcholinesterase-AChE). The results obtain from acute exposure showed interactions between salinity and metformin in SOD activity, body PROT levels and GLY content in G. holbrooki. The data obtain showed that an increase in salinity can modulate the response of the G. holbrooki to metformin. The results obtain from the chronic assay, showed that exposure of G. holbrooki to metformin led to a significant decrease in SOD activity at almost all concentrations tested. In addition, GPx and GSTs activity increased significantly at the concentration of metformin 10 and 5 μ/L, respectively. Therefore, metformin can lead to oxidative stress in G. holbrooki. Overall, the GLY content in G. holbrooki increased after exposure to metformin concentrations. No significant effects were observed in the remaining biomarkers measured. Although this work does not show a full oxidative stress scenario in G. holbrooki after exposure to metformin under different salinities, other studies have already shown that metformin alone can lead to oxidative damage in aquatic species. Therefore, additional ecotoxicological studies should be performed to find out if different metformin concentrations combined with salinity increase might impact non-target species.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-10T00:00:00Z
2021-12-10
2022-03-11T12:02:01Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/33456
url http://hdl.handle.net/10773/33456
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137704240218112